524711
VISTAPH
Start SIP
Invest Now
Start SIP in VISTAPH
Performance
- Low
- ₹8
- High
- ₹9
- 52 Week Low
- ₹8
- 52 Week High
- ₹13
- Open Price₹8
- Previous Close₹8
- Volume3,420
Investment Returns
- Over 1 Month -3.61%
- Over 3 Month -13.48%
- Over 6 Month -21.22%
- Over 1 Year -27.5%
Smart Investing Starts Here Start SIP with Vista Pharmaceuticals for Steady Growth!
Vista Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -7.8
- PEG Ratio
- 0.1
- Market Cap Cr
- 53
- P/B Ratio
- 1.2
- Average True Range
- 0.75
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.16
- RSI
- 44.58
- MFI
- 56.44
Vista Pharmaceuticals Financials
Vista Pharmaceuticals Technicals
EMA & SMA
Current Price
₹8.54
+
0.4
(4.91%)
- Bearish Moving Average 7
- Bullish Moving Average 9
- 20 Day
- ₹8.46
- 50 Day
- ₹8.82
- 100 Day
- ₹9.32
- 200 Day
- ₹10.02
Resistance and Support
8.3
- R3 8.84
- R2 8.71
- R1 8.43
- S1 8.02
- S2 7.89
- S3 7.61
Vista Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-13 | Quarterly Results | |
| 2025-08-13 | Quarterly Results | |
| 2025-05-30 | Audited Results | |
| 2025-02-19 | Preferential Issue of shares & Others | Inter-alia, to consider 1. Notice of the EGM for the approval of raising of funds. 2. Other business matters. |
| 2025-02-12 | Quarterly Results |
Vista Pharmaceuticals F&O
About Vista Pharmaceuticals
- NSE Symbol
- VISTAPH
- BSE Symbol
- 524711
- Managing Director
- Mr. Murali Meraga
- ISIN
- INE427C01021
Similar Stocks to Vista Pharmaceuticals
Vista Pharmaceuticals FAQs
Vista Pharmaceuticals share price is ₹8 As on 01 January, 2026 | 21:27
The Market Cap of Vista Pharmaceuticals is ₹52.6 Cr As on 01 January, 2026 | 21:27
The P/E ratio of Vista Pharmaceuticals is -7.8 As on 01 January, 2026 | 21:27
The PB ratio of Vista Pharmaceuticals is 1.2 As on 01 January, 2026 | 21:27
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.